Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04SOA
|
|||
| Former ID |
DIB005427
|
|||
| Drug Name |
H1N1 pandemic influenza A vaccine
|
|||
| Synonyms |
Panflu; H1N1 pandemic influenza A vaccine, Sinovac; Panflu.1; Split viron vaccine (H1N1 influenza), Sinovac; Split viron vaccine + adjuvant (H1N1 influenza), Sinovac; Whole viron vaccine + adjuvant (H1N1 influenza), Sinovac
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Approved | [1], [2] | |
| Company |
Sinovac Biotech Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [1], [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT01008137) Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults. U.S. National Institutes of Health. | |||
| REF 3 | How Influenza (Flu) Vaccines Are Made. FLU.gov. 2014. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.